Embecta (EMBC) Shares Outstanding (Weighted Average) (2021 - 2026)
Embecta recorded quarterly Shares Outstanding (Weighted Average) of $59.3 million in Q1 2026, up 0.86% quarter-over-quarter from $58.8 million in Q4 2025, and up 2.03% year-over-year from $58.1 million in Q1 2025.
Embecta's Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $59.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 2.03% year-over-year to $59.3 million; the TTM figure through Mar 2026 stood at $59.3 million (up 2.03% YoY), while the FY2025 annual figure was $58.3 million, up 1.09% from the prior year.
- Shares Outstanding (Weighted Average) came in at $59.3 million for Q1 2026 at Embecta, up from $58.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $59.3 million in Q1 2026 to a low of $57.0 million in Q3 2022.
- A 5-year average of $57.8 million and a median of $57.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) fell 1.0% in 2023 and increased 2.03% in 2026, its largest moves.
- Embecta's Shares Outstanding (Weighted Average) stood at $57.1 million in 2022, then grew by 0.65% to $57.5 million in 2023, then advanced by 0.81% to $58.0 million in 2024, then rose by 1.46% to $58.8 million in 2025, then rose by 0.86% to $59.3 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $59.3 million, $58.8 million, and $58.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 145.34 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 72.00 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 174.20 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 195.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 71.43 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 515.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 64.05 Mn |
| 10 | Embecta | 197.17 Mn | 3.77 Mn | 127.80 Mn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.30 Mn |
| Dec 31, 2025 | 58.80 Mn |
| Sep 30, 2025 | 58.31 Mn |
| Jun 30, 2025 | 58.24 Mn |
| Mar 31, 2025 | 58.12 Mn |
| Dec 31, 2024 | 57.95 Mn |
| Sep 30, 2024 | 57.68 Mn |
| Jun 30, 2024 | 57.64 Mn |
| Mar 31, 2024 | 57.58 Mn |
| Dec 31, 2023 | 57.49 Mn |
| Sep 30, 2023 | 57.25 Mn |
| Jun 30, 2023 | 57.22 Mn |
| Mar 31, 2023 | 57.26 Mn |
| Dec 31, 2022 | 57.11 Mn |
| Sep 30, 2022 | 57.02 Mn |
| Jun 30, 2022 | 57.80 Mn |
| Mar 31, 2022 | 57.80 Mn |
| Dec 31, 2021 | 57.01 Mn |
| Sep 30, 2021 | 57.01 Mn |
| Jun 30, 2021 | 57.80 Mn |
| Mar 31, 2021 | 57.80 Mn |